Literature DB >> 194618

Evaluation of 51Cr release for detecting cell-mediated cytotoxic responses to solid chemically induced rat tumours.

M Zöller, M R Price, R W Baldwin.   

Abstract

A 51Cr-release test was developed for the detection of cell-mediated cytotoxicity against transplanted solid chemically induced rat tumours, and the findings were compared with those obtained in parallel tests using a microcytotoxicity assay. It was necessary to incorporate several modifications of the original Brunner assay (Brunner et al., 1968) in order to increase the sensitivity of the test as applied to long-term tumour lines maintained as glass-adherent cultures. These included: 1. preincubation of labelled tumour cells at 37 degrees C for 3-4 h before addition of effector cells; 2. preincubation of effector cells at 37 degrees C for 12 h before addition to target cells; 3. upon admixture of target and effector cells, intimate cell contact was established by gentle centrifugation; 4. after incubation of target and effector cells at 37 degrees C, a further incubation for 1 h at 45 degrees C was included to complete the release of 51Cr from non-viable cells. Maximal cytotoxicity of tumour-bearer effector cells was detected after 12 h incubation of lymphoid and target cells at a ratio of 200:1. Spleen cells from tumour-bearing rats during the first 2 weeks of tumour growth exhibited the same pattern of reactivity in the 51Cr-release test and the microcytotoxicity assay, although significant reduction in target-cell numbers was more frequently recorded using the microcytotoxicity assay. Tumour-bearer spleen cells showed reactivity against the homologous tumour as well as against unrelated tumours. Using either assay, pre-exposure of effector cells to 3M KC1 extracts of tumour was found to inhibit their effect on tumour cells most frequently in tests in which the effector-cell donor, soluble extract and target cell were of the same tumour line.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 194618      PMCID: PMC2025524          DOI: 10.1038/bjc.1977.126

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  22 in total

1.  Cell-mediated immunity to H-2 antigens. Characteristics of the effector cells as detected in the microcytotoxicity assay.

Authors:  H Trostmann; K Pfizenmaier; H Wagner; M Röllinghoff
Journal:  Transplantation       Date:  1976-06       Impact factor: 4.939

2.  Comparison of 51Cr release and microcytotoxicity assays against human melanoma cells.

Authors:  P Hersey; J Edwards; A Edwards; E Adams; R Kearney; G W Milton
Journal:  Int J Cancer       Date:  1975-07-15       Impact factor: 7.396

3.  Evaluation of the cell-mediated immune response to murine sarcoma virus by (125I)iododeoxyuridine assay and comparison with chromium 51 and microcytotoxicity assays.

Authors:  G Fossati; H T Holden; R B Herberman
Journal:  Cancer Res       Date:  1975-09       Impact factor: 12.701

4.  Demonstration of cell-mediated immunity to human neoplasms of various histological types.

Authors:  I Hellström; K E Hellström; H O Sjögren; G A Warner
Journal:  Int J Cancer       Date:  1971-01-15       Impact factor: 7.396

5.  A modified 51Cr release assay for cytotoxic lymphocytes.

Authors:  M Dunkley; R G Miller; K Shortman
Journal:  J Immunol Methods       Date:  1974-12       Impact factor: 2.303

Review 6.  Cell-mediated cytotoxicity, allograft rejection, and tumor immunity.

Authors:  J C Cerottini; K T Brunner
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

7.  Inhibition of cell-mediated cytotoxicity to chemically induced rat tumours by soluble tumour and embryo cell extracts.

Authors:  M Zöller; M R Price; R W Baldwin
Journal:  Int J Cancer       Date:  1976-01-15       Impact factor: 7.396

8.  Cell-mediated cytotoxicity to chemically-induced rat tumours.

Authors:  M Zöller; M R Price; R W Baldwin
Journal:  Int J Cancer       Date:  1975-10-15       Impact factor: 7.396

9.  Comparative in vitro studies on effector cell diversity in the cellular immune response to murine sarcoma virus (MSV)-induced tumors in mice.

Authors:  F Plata; E Gomard; J C Leclerc; J P Levy
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

10.  Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen.

Authors:  G A Currie; C Basham
Journal:  Br J Cancer       Date:  1972-12       Impact factor: 7.640

View more
  1 in total

1.  Tumour-associated antigens reacting with cytotoxic antibodies in serum of hepatoma-bearing rats.

Authors:  P Lando; K Berzins; J Gabriel; P Larsson; P Perlmann
Journal:  Br J Cancer       Date:  1981-10       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.